MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nEnquire Now @ https:\/\/events.marketsandmarkets.com\/2nd-annual-

4 views • 5 slides

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th - 21st June 2024 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.\n\nBecome a Speaker @ \/\/events.marketsandmarkets.com\/2nd-annual-b

1 views • 6 slides

Dr. Jamie Herron, a Consultant Psychiatrist specializing in Huntington's Disease, presents research opportunities including sub-investigator roles in clinical trials like Wave SNP3 and biomarker studies. The portfolio outlines the genetic basis of Huntington's, associated symptoms, and the chance to

2 views • 6 slides

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edi

2 views • 6 slides

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg im Breisgau, Germany.\n\nRegister Now @ \/\/events.marketsandmarkets.com\/immunobio-series\/register

1 views • 6 slides

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany.\n\nRegister Now @ \/\/events.marketsandmarkets.

1 views • 5 slides

Dementia, a syndrome resulting from various diseases affecting nerve cells and brain function, leads to cognitive decline. Treatment approaches include pharmacological and non-pharmacological interventions such as biomarker monitoring, lifestyle modifications, and addressing risk factors like hypert

0 views • 12 slides

Colorado's comprehensive cancer programs are focusing on enhancing cancer surveillance by collecting biomarkers and prognostic factors statewide. The initiative involves multi-phase implementation, bidirectional reporting for genetic counseling services, and increasing testing for targeted therapies

4 views • 17 slides

Strong association of clinical biomarker - elevated DKK2 correlates with poor CRC prognosis. First-in-class therapeutic for colorectal cancer, targeting MSS CRC with multiple novel mechanisms of action and low risk for side effects. Complements current treatments like bevacizumab and shows efficacy

2 views • 11 slides

The Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) commenced in late 2006, with a cohort size and follow-up progress detailed. The study includes assessments and biomarker imaging, such as MRI, amyloid PET, and tau PET scans, with ongoing review cycles and data additions. Current

0 views • 12 slides

This research focuses on evaluating the safety and efficacy of a biomarker-guided approach to determine the duration of antibiotic treatment in hospitalized adult patients with sepsis. The study involves a multi-centre randomized controlled trial to assess if a treatment protocol based on monitoring

0 views • 53 slides

Autosomal Dominant Alzheimer Disease (ADAD) and Sporadic Late Onset Alzheimer Disease (LOAD) show distinct clinical presentations, neuropathological features, and rates of progression. The DIAN-ADNI Comparison Study aims to investigate if ADAD and LOAD share the same pathophysiology and how they res

0 views • 16 slides

This study evaluates the impact of pesticide exposure on farmers' health in Malaysia, Uganda, and the UK using urinary biomarker concentrations. Multiple cohorts are analyzed to assess associations between exposure-modifying factors and urine metabolite measurements. The IMPRESS project focuses on i

0 views • 12 slides

Clinicians traditionally diagnose Alzheimer's Disease (AD) based on clinical criteria, but cerebrospinal fluid (CSF) AD biomarkers offer more reliable detection earlier in the disease course. This article discusses the criteria for lumbar puncture and CSF analysis in the diagnosis of AD, highlightin

0 views • 18 slides

This presentation proposes a new topic group on using artificial intelligence for analyzing human voice as a biomarker in disease prevention, prediction, and monitoring. The focus is on addressing challenges in developing AI solutions for clinical applications, with simulations depicting brain activ

0 views • 13 slides

In biogeochemistry research, advanced analytical techniques are utilized to isolate and separate organic matter, focusing on major carbon pools in bodies of water like Lake Superior. Biomarkers such as fatty acids and specific compounds are identified as indicators for various microbial processes, i

0 views • 11 slides

Explore the latest advancements in diagnostic technology for predicting and diagnosing cardiac conditions like CHD. Learn about new techniques such as high-tech scanning, biomarker identification, and predictive testing, and understand how these innovations can influence insurance products and risk

0 views • 15 slides

A concussion is a form of head injury that occurs due to a direct or indirect hit to the head or body, causing the brain to shift within the skull. It is a transient neurological event with a course of complete recovery in most athletes. Despite no accurate biomarker, it is diagnosed clinically base

0 views • 27 slides

In today's health landscape, trends show a rise in chronic diseases and an aging population, leading to a decentralized healthcare approach. Introducing EGOO, a mobile test unit with smart software for personalized diagnostics. With easy sampling methods and advanced optics to measure biomarkers, it

0 views • 25 slides

A design proposal for early phase clinical trials aiming to quickly establish the worth of a drug for further pursuit in overall indication or biomarker subgroup. The study focuses on enriching BMK+ patients and minimizing the risk of missing efficacy signals through adaptive design strategies. Addr

0 views • 19 slides

This presentation discusses the use of serosurveillance in household surveys to supplement vaccination data collection by testing for biomarkers indicative of vaccination history. It explores the ideal biomarker for vaccination, differences between serosurveillance and vaccination coverage, limitati

0 views • 8 slides

Biomarkers and maturity parameters play crucial roles in characterizing source materials and assessing the thermal maturity of organic matter in petroleum exploration. Specific biomarkers and non-biomarker maturity parameters are utilized to determine the relative maturity of source rocks and oils.

0 views • 17 slides

This study focuses on using mass spectrometry to analyze cerebrospinal fluid (CSF) proteomics in dogs with non-infectious meningoencephalitis, aiming to identify unique peptide signatures for improved diagnosis and monitoring. The research addresses the diagnostic and therapeutic limitations of this

0 views • 16 slides

Sofie's research progress includes training on C. elegans and drosophila, meetings with various groups, preparing for conferences, and application for funding. She is focused on stem cell research, premature aging studies, and biomarker analysis in CSF.

0 views • 12 slides

The ATHENA-HF trial investigates the impact of high-dose spironolactone on reducing NT-proBNP levels in acute heart failure patients. Key objectives include assessing congestion, dyspnea relief, urine output, weight change, diuretic requirement, and outcomes like mortality and readmissions up to 60

0 views • 20 slides

Ongoing breast cancer research projects focusing on biomarker validation, new team initiatives, and imaging advancements are detailed. Notable efforts include the investigation of triple-negative breast cancer markers, benign breast disease progression markers, ER+ and HER2+ biomarkers, and breast c

0 views • 9 slides

Nanomaterials play a crucial role in medicine by serving as drug carriers, bioimaging agents, and therapeutic entities due to their unique properties. In biology, nanotechnology is used for tissue regeneration, biomarker identification, and bioimaging of pathological lesions. The applications of nan

0 views • 16 slides

EDRN investigators can approach the FDA for pre-submission without an industry partner for proposed early detection study designs. The process involves validation, verification, and discovery stages in the biomarker pipeline, utilizing various technologies and biospecimen sets. An example from the o

0 views • 18 slides